Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years

Ryan J. King

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2081-3327; OpenAlex author ID A5029009402. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 4 papers · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 13

  1. Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer. Co-author DOI 10.1186/s12943-025-02340-8↗
  2. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Co-author DOI 10.1038/s41556-024-01372-4↗
  3. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 … Co-author DOI 10.1038/s41556-024-01417-8↗
  4. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Co-author DOI 10.1038/s41388-021-02132-6↗
  5. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Co-author DOI 10.1053/j.gastro.2021.06.045↗
  6. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2020.04.017↗
  7. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Co-author DOI 10.1016/j.canlet.2020.07.025↗
  8. Evaluating the Metabolic Alterations in Pancreatic Cancer. Co-author DOI 10.1007/978-1-4939-8879-2_20↗
  9. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells. Co-author DOI 10.1016/j.canlet.2017.04.029↗
  10. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2017.06.004↗
  11. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-16-3062↗
  12. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-17-1151↗
  13. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Co-author DOI 10.18632/oncotarget.5843↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surendra Kumar Shukla · 13 shared papers, 2015–2026 · strength 1.33
  2. Pankaj Kumar Singh · 12 shared papers, 2015–2024 · strength 1.11
  3. Aneesha Dasgupta · 10 shared papers, 2015–2024 · strength 0.96
  4. Kamiya Mehla · 7 shared papers, 2015–2026 · strength 0.78
  5. Michael Anthony Hollingsworth · 6 shared papers, 2017–2026 · strength 0.77
  6. Kuldeep Singh Attri · 7 shared papers, 2017–2024 · strength 0.75
  7. Divya Murthy · 7 shared papers, 2017–2024 · strength 0.71
  8. Chunbo He · 5 shared papers, 2021–2026 · strength 0.71
  9. Ravi Kumar Thakur · 5 shared papers, 2021–2026 · strength 0.71
  10. Nina V. Chaika · 8 shared papers, 2015–2024 · strength 0.69
  11. Scott E. Mulder · 5 shared papers, 2020–2024 · strength 0.60
  12. Enza Vernucci · 8 shared papers, 2015–2022 · strength 0.59
  13. Tuo Hu · 4 shared papers, 2021–2026 · strength 0.59
  14. Paul M. Grandgenett · 5 shared papers, 2017–2024 · strength 0.55
  15. Venugopal Gunda · 7 shared papers, 2015–2022 · strength 0.52
  16. Sai Sundeep Kollala · 3 shared papers, 2024–2026 · strength 0.50
  17. Jaime Abrego · 6 shared papers, 2017–2022 · strength 0.47
  18. Joshua J. Souchek · 4 shared papers, 2015–2024 · strength 0.38
  19. Spas Dimitrov Markov · 2 shared papers, 2020–2026 · strength 0.33
  20. Robert Powers · 3 shared papers, 2017–2024 · strength 0.32
  21. Teklab Gebregiworgis · 3 shared papers, 2017–2024 · strength 0.32
  22. Rosa F. Hwang · 2 shared papers, 2024 · strength 0.28
  23. Ajay Jain · 2 shared papers, 2024 · strength 0.28
  24. Vikrant Rai · 2 shared papers, 2024 · strength 0.28
  25. Barish H. Edil · 2 shared papers, 2024 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.